Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 9, 2016 - Issue
Submit an article Journal homepage
217
Views
58
CrossRef citations to date
0
Altmetric
Original Research

Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany

Qing Qiao1 Global Medicines Development, AstraZeneca, Gothenburg, Sweden
,
Mario JNM Ouwens1 Global Medicines Development, AstraZeneca, Gothenburg, Sweden
,
Susan Grandy2 Global Medicines Development, AstraZeneca, Gaithersburg, MD, USA
,
Kristina Johnsson1 Global Medicines Development, AstraZeneca, Gothenburg, Sweden
&
Karel Kostev3 Epidemiology and Evidence-Based Medicine, Real-World Evidence Solutions, IMS Health, Frankfurt am Main, GermanyCorrespondence[email protected]
Pages 201-205 | Published online: 28 Jun 2016

References

  • Holst JJ Vilsboll T Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings Diabetes Obes Metab 2013 15 1 3 14 22646532
  • Werner U Effects of the GLP-1 receptor agonist lixisenatide on postprandial glucose and gastric emptying: preclinical evidence J Diabetes Complications 2014 28 1 110 114 23992745
  • Garber AJ Long-acting glucagon-like peptide 1 receptor agonists. A review of their efficacy and tolerability Diabetes Care 2011 34 suppl 2 S279 S284 21525469
  • García-Pérez LE Alvarez M Dilla T Gil-Guillén V Orozco-Beltrán D Adherence to therapies in patients with type 2 diabetes Diabetes Ther 2013 4 2 175 194 23990497
  • Richter H Dombrowski S Hamer H Hadji P Kostev K Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology Ger Med Sci 2015 13 Doc14 26339224
  • Swart E Gothe H Geyer S German Society for Social Medicine and Prevention German Society for Epidemiology Gute Praxis Sekundärdatenanalyse (GPS): Leitlinien und Empfehlungen. [Good practice of secondary data analysis (GPS): guidelines and recommendations] Gesundheitswesen 2015 77 2 120 126 German 25622207
  • Buysman EK Liu F Hammer M Langer J Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort study Adv Ther 2015 32 4 341 355 25832470
  • Currie CJ Peyrot M Morgan CL The impact of treatment noncompliance on mortality in people with type 2 diabetes Diabetes Care 2012 35 6 1279 1284 22511257
  • Johnston SS Nguyen H Felber E Retrospective study of adherence to glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes mellitus in the United States Adv Ther 2014 31 11 1119 1133 25408484
  • Polonsky WH Fisher L Hessler D Bruhn D Best JH Patient perspectives on once-weekly medications for diabetes Diabetes Obes Metab 2011 13 2 144 149 21199266
  • Malmenäs M Bouchard JR Langer J Retrospective real-world adherence in patients with type 2 diabetes initiating once-daily liraglutide 1.8 mg or twice-daily exenatide 10 μg Clin Ther 2013 35 6 795 807 23642290
  • Iglay K Cartier SE Rosen VM Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes Curr Med Res Opin 2015 31 7 1283 1296 26023805

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.